TickerFiles

ADAPTIN BIO, INC. 10-Q filing

Filed 2025-11-14 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001213900-25-110559
Form type
10-Q
CIK
0001938571
Primary document
https://www.sec.gov/Archives/edgar/data/1938571/000121390025110559/ea0263462-10q_adaptin.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ADAPTIN BIO, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-4.0M--
Net Income$-3.8M--
Eps Basic-0.5--
Eps Diluted-0.5--
Cash And Equivalents$579,089--
Total Assets$979,474--
Total Liabilities$1.9M--
Shareholders Equity$-881,078--
Operating Cash Flow$-4.1M--